Similar regions of human chromosome 3 are eliminated from or retained in human/human and human/mouse microcell hybrids during tumor growth in severe combined immunodeficient (SCID) mice
- 30 January 2001
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 98 (3) , 1136-1141
- https://doi.org/10.1073/pnas.98.3.1136
Abstract
By passaging microcell hybrids (MCHs) containing human chromosome 3 (chr3) on A9 mouse fibrosarcoma background through severe combined immunodeficient (SCID) mice (elimination test), we have previously defined a 1-Mb-long common eliminated region 1 (CER1) at 3p21.3, a second eliminated region (ER2) at 3p21.1-p14 and a common retained region (CRR) at 3q26-qter. In the present work, chr3 was transferred by microcell fusion into the human nonpapillary renal cell carcinoma line KH39 that contained uniparentally disomic chr3. Four MCHs were generated. Compared with KH39, they developed fewer and smaller tumors, which grew after longer latency periods in SCID mice. The tumors were analyzed in comparison with corresponding MCHs by chr3 arm-specific painting, 19 fluorescent in situ hybridization (FISH) probes, and 27 polymorphic markers. Three MCHs that maintained the intact exogenous chr3 in vitro lost one 3p copy in all 11 tumors. Seven of 11 tumors lost the exogenous 3p, whereas four tumors contained mixed cell populations that lacked either the exogenous or one endogenous KH39 derived 3p. In one MCH the exogenous chr3 showed deletions within CER1 and ER2 already in vitro. It remained essentially unchanged in 8/9 derived tumors. The third, exogenous copy of the 3q26-q27 region (part of CRR) was retained in 16/20 tumors. It can be concluded that the human/human MCH-based elimination test identifies similar eliminated and retained regions on chr3 as the human/murine MCH-based test.Keywords
This publication has 38 references indexed in Scilit:
- Combined LOH/CGH analysis proves the existence of interstitial 3p deletions in renal cell carcinomaOncogene, 2000
- A 1-Mb PAC Contig Spanning the Common Eliminated Region 1 (CER1) in Microcell Hybrid-Derived SCID TumorsGenomics, 1999
- Involvement of multiple loci on chromosome 3 in renal cell cancer developmentGenes, Chromosomes and Cancer, 1997
- Multiple pathways to cellular senescence: Role of telomerase repressorsEuropean Journal Of Cancer, 1997
- A breakpoint map of recurrent chromosomal rearrangements in human neoplasiaNature Genetics, 1997
- An STS-Based Map of the Human GenomeScience, 1995
- Construction and characterization of a highly stable human:rodent monochromosomal hybrid panel for genetic complementation and genome mapping studiesCytogenetic and Genome Research, 1995
- Nonrandom loss of human chromosome 3 fragments from mouse-human microcell hybrids following progressive growth in SCID miceGenes, Chromosomes and Cancer, 1994
- Characterization of an 800 kb region at 3p22-p21.3 that was homozygously deleted in a lung cancer cell lineHuman Molecular Genetics, 1994
- Suppression of Malignancy by Cell FusionNature, 1969